Europe Artificial Blood Substitutes Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Europe Artificial Blood Substitutes Market Analysis

  • Healthcare
  • Published Report
  • Jul 2021
  • Europe
  • 350 Pages
  • No of Tables: 54
  • No of Figures: 25

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. Currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. primary interviews with key opinion leaders
    7. MULTIVARIATE MODELLING
    8. PRODUCT TYPE LIFELINE CURVE
    9. DBMR MARKET POSITION GRID
    10. market APPLICATION coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. PATENT ANALYSIS OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. DBMR ANALYSIS
    2. COUNTRY-LEVEL ANALYSIS
    3. YEARWISE ANALYSIS
  6. EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: PIPELINE ANALYSIS
  7. Market Overview
    1. drivers
      1. IncreasE IN demand for blood transfusion
      2. Increased funding for product development
      3. rise in blood-related disorders and trauma cases
      4. limited availability of fresh blood and small storage periods of fresh blood
    2. Restraints
      1. stringent regulatory approval process
      2. high-cost production of artificial blood substitute
      3. unawareness about the artificial blood substitutes
    3. OPPORTUNITIES
      1. increase in awareness regarding the advantages of artificial blood over human blood
      2. risE IN demand for blood substituteS and insufficient number of blood donors
      3. RISE IN number of research & developments on artificial blood
      4. ample amount of sources for production of artificial blood substitute
    4. Challenges
      1. instability of artificial blood product
      2. extended clinical trails
      3. side effects of artificial blood substitutes
  8. IMPACT OF COVID-19 ON THE EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. Aftermath of COVID-19
    2. Impact on Supply and Demand
    3. The increasing demand for blood transfusion is leading the artificial blood substitutes market.
    4. Conclusion
  9. Europe Artificial blood substitutes market, by Product Type
    1. overview
    2. Hemoglobin-Based Oxygen Carries (HBOCS)
      1. oxyglobin
      2. hemopure
    3. Perfluorocarbon (PFCS)
      1. perftoran
      2. others
  10. Europe Artificial blood substitutes market, by Source
    1. overview
    2. animal blood
    3. Human Blood
    4. Microorganism Based Recombinant Hb
    5. Stem Cells
    6. Synthetic Polymers
  11. Europe Artificial blood substitutes market, by Application
    1. overview
    2. injuries
    3. Cardiovascular Diseases
    4. Organ Transplant
    5. Maternal Condition
    6. Malignant Neoplasma
    7. Neonatal Conditions
  12. Europe Artificial blood substitutes market, by End user
    1. overview
    2. hospital and clinics
    3. blood banks
    4. others
  13. Europe Artificial blood SUBSTITUTEs MARKET, by Region
    1. EUROPE
      1. FRANCE
      2. RUSSIA
      3. NETHERLAND
      4. U.K.
      5. REST OF EUROPE
  14. Europe artificial blood substitutes market: COMPANY landscape
    1. company share analysis: Europe
  15. swot
  16. company profile
    1. kalocyte, inc.
      1. COMPANY SNAPSHOT
      2. Company sahre Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    2. hemarina
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    3. hemoglobin oxygen therapeutics llc
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    4. llc “visusmed”
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    5. European Medicines Agency
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. company share analysis
      4. PRODUCT PORTFOLIo
      5. RECENT DEVELOPMENT
    6. aurum biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    7. boston therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    8. nanoblood llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    9. nuvox pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    10. opk biotech llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    11. oxyvita inc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    12. prolong pharmaceuticals, llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

List of Table

TABLE 1 Europe Artificial blood substitutes Market, Product Type, 2019-2028 (USD Thousand)

TABLE 2 Europe Hemoglobin-Based Oxygen Carries (HBOCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 3 Europe HEMOGLOBIN-based oxygen carriers (HBOCs) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 4 Europe Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 5 Europe Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 6 Europe Artificial blood substitutes Market, by Source, 2019-2028 (USD Thousand)

TABLE 7 Europe animal blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 8 Europe human blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 9 Europe microorganism based recombinant hb in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 10 Europe stem cells in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 11 Europe synthetic polymers in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 12 Europe Artificial blood substitutes Market, by Application, 2019-2028 (USD Thousand)

TABLE 13 Europe injuries in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 14 Europe cardiovascular diseases in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 15 Europe organ transplant in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 16 Europe maternal condition in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 17 Europe malignant neoplasma in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 18 Europe neonatal conditions in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 19 Europe Artificial blood substitutes Market, by End user, 2019-2028 (USD Thousand)

TABLE 20 Europe hospitals and clinics in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 21 Europe blood banks in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 22 Europe others in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 23 Europe artificial blood substitute Market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 24 EUROPE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 25 Europe Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 26 Europe Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 27 Europe artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 28 Europe artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 29 Europe artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 30 FRANCE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 31 FRANCE Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 32 FRANCE Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 33 FRANCE artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 34 FRANCE artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 35 FRANCE artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 36 RUSSIA artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 37 RUSSIA Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 38 RUSSIA Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 39 RUSSIA artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 40 RUSSIA artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 41 RUSSIA artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 42 NETHERLAND artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 43 NETHERLAND Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 44 NETHERLAND Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 45 NETHERLAND artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 46 NETHERLAND artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 47 NETHERLAND artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 48 U.K. artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 49 U.K. Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 50 U.K. Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 51 U.K. artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 52 U.K. artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 53 U.K. artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 54 REST OF EUROPE ARTIFICIAL blood substitute Market, By Product type, 2019-2028 (USD Thousand)

List of Figure

FIGURE 1 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: segmentation

FIGURE 2 Europe artificial blood substitutes market: data triangulation

FIGURE 3 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: DROC ANALYSIS

FIGURE 4 Europe artificial blood substitutes market: EUROPE vs REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: market APPLICATION COVERAGE GRID

FIGURE 9 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: SEGMENTATION

FIGURE 11 increased DEMAND FOR BLOOD TRANSFUSION is expected to drive the Europe artificial blood substitutes market in THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 haemoglobin-based oxygen carriers (hbocs) SEgment is expected to account for the largest share of the EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET in 2021 & 2028

FIGURE 13 PATENT REGISTERED FOR ARTIFICIAL BLOOD SUBSTITUTES, BY COUNTRY

FIGURE 14 PATENT REGISTERED YEAR (2017 - 2021)

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF EUROPE artificial blood substituteS MARKET

FIGURE 16 Europe Artificial blood substitutes Market, By Product Type, 2020

FIGURE 17 Europe Artificial blood substitutes Market, By Source, 2020

FIGURE 18 Europe Artificial blood substitutes Market, By Application, 2020

FIGURE 19 Europe Artificial blood substitutes Market, By End user, 2020

FIGURE 20 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: SNAPSHOT (2020)

FIGURE 21 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020)

FIGURE 22 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2021 & 2028)

FIGURE 23 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020 & 2028)

FIGURE 24 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY product type (2021-2028)

FIGURE 25 Europe artificial blood substitutes market: company share 2020 (%)